Primary outcomes by 1q21+ status for isatuximab-treated patients with relapsed/refractory multiple myeloma: subgroup analyses from ICARIA-MM and IKEMA.
作者信息
Martin Tom, Richardson Paul G, Facon Thierry, Moreau Philippe, Perrot Aurore, Spicka Ivan, Bisht Kamlesh, Inchauspé Marlene, Casca France, Macé Sandrine, Van de Velde Helgi, Suzuki Kenshi
机构信息
UCSF Medical Center, San Francisco, CA.
Dana-Farber Cancer Institute, Boston, MA.
出版信息
Haematologica. 2022 Oct 1;107(10):2485-2491. doi: 10.3324/haematol.2022.280660.
Abstract
摘要
Zotero 插件